News
ASRT
1.150
-0.86%
-0.010
Weekly Report: what happened at ASRT last week (0610-0614)?
Weekly Report · 5d ago
Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. The Dow Jones index closed lower by around 0.1% on Wednesday. Recent notable insider transactions for penny stocks include Kronos Bio and Assertio Holdings. Investors and traders interested in penny stocks can consider this a factor.
Benzinga · 06/13 13:10
Weekly Report: what happened at ASRT last week (0603-0607)?
Weekly Report · 06/10 11:07
Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed higher by around 80 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Benzinga takes a look at a few recent notable insider transactions for penny stocks. PodcastOne, Inc. And BigBear.ai Holdings are among the companies involved in the trade.
Benzinga · 06/07 11:48
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Assertio Holdings, Inc. Granted the Company’s new Chief Executive Officer, Brendan P. O’Grady, 500,000 restricted stock units and 1,800,000 stock options effective May 31, 2024. Assertio is a pharmaceutical company with comprehensive commercial capabilities.
Barchart · 06/06 15:05
Weekly Report: what happened at ASRT last week (0527-0531)?
Weekly Report · 06/03 11:10
Assertio Therapeutics’ Governance and Shareholder Decisions Update
TipRanks · 05/30 21:27
Nektar, Verastem among healthcare additions in Russell Microcap; Assertio, Sangamo removed
Nektar, Verastem among healthcare additions in Russell Microcap; Assertio, Sangamo removed from the index. 213 companies will be added and 198 deleted from the annual 2024 Russell index reconstitution. Inovio Pharmaceuticals, Nektar, Ocugen among notable additions.
Seeking Alpha · 05/30 20:55
Russell 3000: Inovio, Ocugen among healthcare additions; Assertio, Ginkgo Bioworks among deletions
Healthcare Russell 3000: Inovio, Ocugen among healthcare additions; Assertio, Ginkgo Bioworks among deletions. 225 securities will be added and 144 will be deleted as part of the annual reconstitution. The Russell 3000 index will have a new look on June 28.
Seeking Alpha · 05/30 19:54
Analysts Are Bullish on These Healthcare Stocks: Assertio Therapeutics (ASRT), SurModics (SRDX)
TipRanks · 05/29 13:00
Assertio Therapeutics Welcomes Brendan O’Grady as New CEO
TipRanks · 05/29 12:52
Assertio names Brendan O’Grady as its new CEO
Assertio names Brendan O’Grady as its new CEO and a member of the board. O'Grady is an industry veteran with more than 30 years of experience. Assertio Holdings, Inc. (ASRT) named Brendan O' grady as new CEO.
Seeking Alpha · 05/29 11:23
*Assertio Announces the Appointment of Brendan P. O'Grady as New CEO >ASRT
Dow Jones · 05/29 11:03
ASSERTIO ANNOUNCES THE APPOINTMENT OF BRENDAN P. O’GRADY AS NEW CEO
Reuters · 05/29 11:00
Press Release: Assertio Announces the Appointment of Brendan P. O'Grady as New CEO
Dow Jones · 05/29 11:00
Assertio Holdings Initiated at Buy by Alliance Global Partners
Dow Jones · 05/28 17:10
Assertio Holdings Price Target Announced at $2.75/Share by Alliance Global Partners
Dow Jones · 05/28 17:10
ASSERTIO HOLDINGS INC <ASRT.O>: ALLIANCE GLOBAL PARTNERS INITIATES COVERAGE WITH BUY RATING AND $2.75 PRICE TARGET
Reuters · 05/28 11:03
U.S. RESEARCH ROUNDUP-Autodesk, Equinix, Texas Roadhouse
Wall Street securities analysts revise ratings and price targets on several companies. Autodesk, Equinix, Texas Roadhouse and 3M among those revised on Tuesday. Analysts cut target price to $260 from $320 for Autodek, $922 for equinix and $184 for roadhouse.
Reuters · 05/28 07:01
Weekly Report: what happened at ASRT last week (0520-0524)?
Weekly Report · 05/27 11:14
More
Webull provides a variety of real-time ASRT stock news. You can receive the latest news about Assertio Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About ASRT
Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).